Proceedings of the 2026 3rd International Conference on Applied Economics, Management Science and Social Development (AEMSS 2026)

<Previous Article In Volume
Next Article In Volume>

Economic Consequences of National Organized Drug Centralized Volume Procurement Policy—A Review of Empirical Literature

Authors
Jingyi Cheng1, *
1School of Finance, Southwestern University of Finance and Economics, Liutai Avenue, Chengdu, China
*Corresponding author. Email: 42304255@smail.swufe.edu.cn
Corresponding Author
Jingyi Cheng
Available Online 12 May 2026.
DOI
10.2991/978-94-6239-672-2_25How to use a DOI?
Keywords
National Organized Drug Centralized Volume Procurement; Economic Consequences; Pharmaceutical Enterprise; Literature Review; Pharmaceutical Industry
Abstract

The implementation of China’s National Organized Drug Centralized Volume Procurement (NCDP) policy represents a historic shift in drug pricing in the world’s largest pharmaceutical market. This paper reviews research on the policy’s mechanisms and economic impacts on pharmaceutical firms and the industry, identifies limitations in existing studies—such as overreliance on listed companies, limited long-term analysis, and insufficient heterogeneity assessment—and proposes future research directions, including longitudinal tracking, refined impact analysis, and comprehensive evaluation of the industrial chain ecosystem. The findings aim to inform scholars and support policy improvement.

Copyright
© 2026 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

<Previous Article In Volume
Next Article In Volume>
Volume Title
Proceedings of the 2026 3rd International Conference on Applied Economics, Management Science and Social Development (AEMSS 2026)
Series
Advances in Economics, Business and Management Research
Publication Date
12 May 2026
ISBN
978-94-6239-672-2
ISSN
2352-5428
DOI
10.2991/978-94-6239-672-2_25How to use a DOI?
Copyright
© 2026 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

risenwbib
TY  - CONF
AU  - Jingyi Cheng
PY  - 2026
DA  - 2026/05/12
TI  - Economic Consequences of National Organized Drug Centralized Volume Procurement Policy—A Review of Empirical Literature
BT  - Proceedings of the 2026 3rd International Conference on Applied Economics, Management Science and Social Development (AEMSS 2026)
PB  - Atlantis Press
SP  - 263
EP  - 277
SN  - 2352-5428
UR  - https://doi.org/10.2991/978-94-6239-672-2_25
DO  - 10.2991/978-94-6239-672-2_25
ID  - Cheng2026
ER  -